Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

December 7, 2021

FDA approves Cortrophin Gel for rheumatoid arthritis, multiple sclerosis

  • Misc. MS Related
    /
November 2021 The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis,…
Misc. MS Related

December 7, 2021

Relapse comparable among common DMTs for MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Dimethyl fumarate and fingolimod appeared to have no significant difference in relapse rates, and rituximab appeared to have better relapse…
MS Drug Therapies

December 7, 2021

Timing of rituximab infusion not tied to risk for COVID-19 hospitalization

  • #COVID-19
    /
  • MS Drug Therapies
    /
 December 6, 2021 The timing of rituximab infusion or cumulative lifetime rituximab dose did not appear statistically significantly associated with…
#COVID-19

December 6, 2021

What are the different kinds of Multiple sclerosis pain?

  • MS Pain and Side Effects
    /
 Special to Gulf News   Understanding and being able to communicate the different types of pain is key If you’re reading…
MS Pain and Side Effects

December 6, 2021

What Causes MS?

  • Multiple Sclerosis
    /
  Overview The cause of MS is not known. Scientists believe MS is triggered by a combination of factors. To…
Multiple Sclerosis

December 6, 2021

Video: Lean into Life’s Turns, while living with Multiple Sclerosis

  • An MS Patients Story
    /
Listen to MS Patient Paul Pelland’s motivational story, involving his motorcycle and MS    Visit our MS Learning Channel on…
An MS Patients Story

December 6, 2021

Managing MS – A Roadmap to Navigate Multiple Sclerosis, by Debbie Petrina

  • An MS Patients Story
    /
It’s done!  The second edition of my book Managing MS is out, and I would love for you to read…
An MS Patients Story

November 30, 2021

Results of International Mesenchymal Stem Cell Trial Suggest No Benefits Against Inflammation in Active MS

  • Additional MS resource sites
    /
  • Stem Cell Related
    /
 November 4, 2021 Results have been published from a phase 2 clinical trial conducted at 15 sites in 9 countries,…
Additional MS resource sites

November 30, 2021

Teriflunomide Study in Kids with MS Does Not Meet Primary Endpoint, But Reduces MRI Activity

  • MS Research Study and Reports
    /
 November 29, 2021 —Do We Need Different Ways to Measure Treatment Effectiveness in Children with MS?In a recently published study…
MS Research Study and Reports

November 29, 2021

Siponimod’s Efficacy on Secondary Progressive MS in Older age groups

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 October 28, 2021   –    Le Hua, MD ranscript below. Le Hua, MD: The original EXPAND study had been presented, so…
MS Drug Therapies

Categories

Latest Blog Posts